ESC Professional Premium Access

Evaluating risk factors, biomarkers and management of myocarditis following treatment with checkpoint inhibitors. A retrospective analysis.

Congress Session

About the speaker

Doctor Mustafa Omar Abdimalik

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

7 more presentations in this session

Trends in the prevalence of infiltrative cardiomyopathy among patients with in-hospital cardiac arrest- insight from the US national inpatient sample database

Speaker: Doctor S. Nandy (Bronx, US)

Thumbnail

HCM-AF South Italy score for prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy: data from a derivation and validation italian cohorts.

Speaker: Doctor G. Todde (Naples, IT)

Thumbnail

Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany

Speaker: Doctor M. Tome Esteban (London, GB)

Thumbnail

Genetic and clinical characteristics of transthyretin cardiac amyloidosis in Koreans

Speaker: Doctor K. Jeon (Seoul, KR)

Thumbnail

Cardiomyopathy and cardiovascular events by gender in a comprehensive Finnish patient population with Fabry disease

Speaker: Doctor K. Valtola (Kuopio, FI)

Thumbnail

Access the full session

National registries for rare myocardial diseases

Speakers: Doctor M. Abdimalik, Doctor S. Nandy, Doctor G. Todde, Doctor M. Tome Esteban, Doctor K. Jeon...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk